Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
Telcagepant 300 mg is effective as an acute treatment for migraine with efficacy comparable to that of zolmitriptan 5 mg, a widely-used migraine treatment, but with fewer associated adverse effects. These are the conclusions of an Article published Online first and in and upcoming edition of The Lancet, written by Dr Tony Ho, Merck Research Laboratories, North Wales, Philadelphia, USA, and colleagues.
Related Posts
Tags: effective, migraine, phase, proven, safe, telcagepant, treatment, trial
This entry was posted on Friday, January 16th, 2009 at 10:01 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



